GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Inventories, Raw Materials & Components

PolyPeptide Group AG (XSWX:PPGN) Inventories, Raw Materials & Components : CHF68.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Inventories, Raw Materials & Components?

PolyPeptide Group AG's inventories, raw materials & components for the quarter that ended in Dec. 2023 was CHF68.0 Mil.

PolyPeptide Group AG's quarterly raw materials declined from Dec. 2022 (CHF60.6 Mil) to Jun. 2023 (CHF0.0 Mil) but then increased from Jun. 2023 (CHF0.0 Mil) to Dec. 2023 (CHF68.0 Mil).

PolyPeptide Group AG's annual raw materials increased from Dec. 2021 (CHF40.3 Mil) to Dec. 2022 (CHF60.6 Mil) and increased from Dec. 2022 (CHF60.6 Mil) to Dec. 2023 (CHF68.0 Mil).


PolyPeptide Group AG Inventories, Raw Materials & Components Historical Data

The historical data trend for PolyPeptide Group AG's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Inventories, Raw Materials & Components Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 23.73 35.09 40.33 60.63 67.97

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.33 - 60.63 - 67.97

PolyPeptide Group AG Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry
Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines